Clinical Trials Directory

Trials / Unknown

UnknownNCT02545569

Evaluation of New Custom Made Hearing Product Technology and Shell Modification

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Phonak AG, Switzerland · Industry
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Accepted

Summary

The purpose of this evaluation is to receive the greatest benefit of new custom made hearing product technology and shell modification for the end customer and to continual improve the custom made hearing products.

Detailed description

This is a controlled, single blinded comparative study which is conducted monocentric at Phonak Headquarters in Staefa. The purpose of the studies is to evaluate the strengths and weaknesses of new custom product development in comparison to existing/old products. The results should promote the custom product development, to provide a maximum of benefit and wearing comfort to the hearing aid user.

Conditions

Interventions

TypeNameDescription
DEVICEhearing aid (MD class IIa) - ITE, BTE, RICHearing aid means any wearable instrument or device designed for, offered for the purpose of, or represented as aiding persons with or compensating for, impaired hearing.

Timeline

Start date
2020-01-06
Primary completion
2020-12-01
Completion
2020-12-01
First posted
2015-09-10
Last updated
2019-08-30

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT02545569. Inclusion in this directory is not an endorsement.

Evaluation of New Custom Made Hearing Product Technology and Shell Modification (NCT02545569) · Clinical Trials Directory